School of Media and Communication, Shanghai Jiao Tong University, Shanghai, China.
China Institute for Urban Governance, Shanghai Jiao Tong University, Shanghai, China.
Int J Public Health. 2021 Oct 25;66:1604092. doi: 10.3389/ijph.2021.1604092. eCollection 2021.
China was believed to be the country with the world's highest acceptance rate of the COVID-19 vaccine following several investigations. This study aims to explore the Chinese acceptance of a COVID-19 vaccine before it is made available, including its determinants. A cross-national online survey was conducted covering all 31 provinces of mainland China. The survey consists of the demographic variables, acceptance of a self-paid COVID-19 vaccine as the dependent variable, and the 3Cs factors (i.e., confidence, convenience, and complacency) as the independent variables. Among the 1,532 participants, 57.9% accepted to get a self-paid COVID-19 vaccine. COVID-19 vaccine acceptors were more likely to be concerned about the effectiveness of the vaccines, believe that they were at risk of COVID-19 infection, have a high perceived susceptibility of COVID-19, and trust in the health care system. Findings indicate that the critical task in the early stage of the COVID-19 vaccine development in China is to increase the tolerance to some intuitive concerns about the vaccines, put more emphasis on the communication of the saliency of the disease threats, and effectively translate people's trust in the government into vaccine acceptance.
经过多项调查，中国被认为是世界上对新冠疫苗接种率最高的国家。本研究旨在探讨在新冠疫苗上市前中国人对其的接受程度，包括其决定因素。本研究采用跨国在线调查，涵盖中国大陆的 31 个省。该调查由人口统计学变量、对自费新冠疫苗的接受程度作为因变量，以及 3C 因素（即信心、便利和自满）作为自变量组成。在 1532 名参与者中，57.9%的人表示愿意接种自费新冠疫苗。新冠疫苗的接受者更关注疫苗的有效性，认为自己有感染新冠的风险，对新冠的易感性高，并信任医疗体系。研究结果表明，在中国新冠疫苗研发的早期阶段，关键任务是提高对疫苗的一些直观担忧的容忍度，更加注重疾病威胁的显著性的沟通，并将人们对政府的信任有效地转化为疫苗的接受程度。
